- Biotech Investment Awards: The Multiple Myeloma Research Foundation (MMRF) seeks proposals for its Biotech Investment Award program (BIA). The goal of this initiative is to drive and accelerate the development of innovative and effective treatments for myeloma. This program is designed to: a) provide resources necessary for biotechnology and pharmaceutical companies to rapidly test therapeutics in multiple myeloma; and b) to foster collaboration with academic myeloma experts, as needed. BIA aims to remove barriers that limit the development of novel drugs for myeloma. This is a milestone-driven initiative. Payments will be made after successful completion of milestones as outlined in each applicant's proposal.